| __timestamp | Agios Pharmaceuticals, Inc. | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 5114000 |
| Thursday, January 1, 2015 | 35992000 | 13403000 |
| Friday, January 1, 2016 | 50714000 | 31056000 |
| Sunday, January 1, 2017 | 71124000 | 35845000 |
| Monday, January 1, 2018 | 114145000 | 48294000 |
| Tuesday, January 1, 2019 | 132034000 | 63488000 |
| Wednesday, January 1, 2020 | 149070000 | 88208000 |
| Friday, January 1, 2021 | 121445000 | 102802000 |
| Saturday, January 1, 2022 | 121673000 | 102464000 |
| Sunday, January 1, 2023 | 119903000 | 76162000 |
| Monday, January 1, 2024 | 156784000 | 72977000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis focuses on the Selling, General, and Administrative (SG&A) expenses of two pioneering companies: Agios Pharmaceuticals, Inc. and CRISPR Therapeutics AG, from 2014 to 2023.
Agios Pharmaceuticals has shown a steady increase in SG&A expenses, peaking in 2020 with a 680% rise from 2014. This growth reflects their aggressive expansion and investment in administrative capabilities.
CRISPR Therapeutics, known for its groundbreaking gene-editing technology, also saw a significant increase in SG&A expenses, with a 1,900% surge by 2021. However, a notable decline in 2023 suggests a strategic shift or cost optimization.
These trends highlight the contrasting strategies of these biotech giants, offering insights into their operational priorities and market positioning.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Agios Pharmaceuticals, Inc.
Neurocrine Biosciences, Inc. vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Viatris Inc. or CRISPR Therapeutics AG
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Opthea Limited and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
CRISPR Therapeutics AG or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
CRISPR Therapeutics AG or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and Viridian Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.